| Product NDC: | 0641-6035 |
| Proprietary Name: | Glycopyrrolate |
| Non Proprietary Name: | Glycopyrrolate |
| Active Ingredient(s): | .2 mg/mL & nbsp; Glycopyrrolate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0641-6035 |
| Labeler Name: | West-ward Pharmaceutical Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017558 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19750206 |
| Package NDC: | 0641-6035-25 |
| Package Description: | 25 VIAL in 1 CARTON (0641-6035-25) > 5 mL in 1 VIAL (0641-6035-01) |
| NDC Code | 0641-6035-25 |
| Proprietary Name | Glycopyrrolate |
| Package Description | 25 VIAL in 1 CARTON (0641-6035-25) > 5 mL in 1 VIAL (0641-6035-01) |
| Product NDC | 0641-6035 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Glycopyrrolate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19750206 |
| Marketing Category Name | NDA |
| Labeler Name | West-ward Pharmaceutical Corp. |
| Substance Name | GLYCOPYRROLATE |
| Strength Number | .2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |